Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
28.7M
-
Shares change
-
-864K
-
Total reported value, excl. options
-
$808M
-
Value change
-
-$33M
-
Put/Call ratio
-
0.45
-
Number of buys
-
90
-
Number of sells
-
-105
-
Price
-
$28.10
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2022
233 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q3 2022.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.7M shares
of 46.4M outstanding shares and own 61.97% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.15M shares), FEDERATED HERMES, INC. (3.27M shares), VANGUARD GROUP INC (2.61M shares), DIMENSIONAL FUND ADVISORS LP (1.84M shares), STATE STREET CORP (1.53M shares), PRICE T ROWE ASSOCIATES INC /MD/ (809K shares), FULLER & THALER ASSET MANAGEMENT, INC. (715K shares), GEODE CAPITAL MANAGEMENT, LLC (708K shares), Invesco Ltd. (588K shares), and RENAISSANCE TECHNOLOGIES LLC (434K shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.